Sanara MedTech Inc. SMTI Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 92.7%+2.1pp | 90.6%+2.7pp | 87.9%+1.8pp | 86.1%-6.3pp | |
| Operating margin | 4.6%+6.2pp | -1.6%+4.9pp | -6.5%+20.8pp | -27.3%-3.1pp | |
| Net margin | -36.4%-25.3pp | -11.2%-4.5pp | -6.6%+10.7pp | -17.3%+8.7pp | |
| EBITDA margin | 8.5%+4.4pp | 4.1%+4.9pp | -0.8%+21.3pp | -22.1%+0.2pp | |
| Returns | |||||
| Return on equity | -165.7%-143pp | -22.9%-13.0pp | -9.9%+12.0pp | -21.9%+21.2pp | |
| Return on assets | -46.7%-34.7pp | -11.9%-5.6pp | -6.4%+9.9pp | -16.3%+18.0pp | |
| Return on invested capital | 10.3%+12.8pp | -2.6%+7.3pp | -9.9%+44.4pp | -54.3%+25.1pp | |
| Efficiency | |||||
| Asset turnover | 1.3×+0.2× | 1.1×+0.1× | 1×0.0× | 0.9×-0.4× | |
| Inventory turnover | 2.2×+0.1× | 2.2×+0.3× | 1.9×-0.4× | 2.3×+0.8× | |
| Liquidity | |||||
| Current ratio | 1.8×-0.4× | 2.2×+0.8× | 1.4×-0.2× | 1.6×-2.5× | |
| Quick ratio | 1.6×-0.4× | 2×+1.0× | 1×-0.3× | 1.3×-2.4× | |
| Cash ratio | 0.9×-0.1× | 1×+0.7× | 0.4×-0.3× | 0.7×-2.4× | |
| Leverage | |||||
| Debt-to-equity | 8.1×+7.3× | 0.8×+0.6× | 0.3×+0.2× | 0×0.0× | |
| Debt-to-assets | 0.7×+0.3× | 0.4×+0.2× | 0.2×+0.1× | 0×0.0× | |
| Net debt / EBITDA | 3.6×-1.0× | 4.6×— | —— | —— | |
| Interest coverage | 0.7×+1.1× | -0.4×+8.4× | -8.9×+35.1× | -44×+10,330× | |
| Per Share | |||||
| Book value per share | $0.69-85.2% | $4.64-14.2% | $5.42+2.4% | $5.29+26.8% | |
| Valuation | |||||
| Market capitalization | $216.18M-9.7% | $290.21M-17.3% | $350.8M-7.1% | $377.65M+68.0% | |
| Enterprise value | $250.95M-6.5% | $306.61M-14.2% | $357.44M-3.3% | $369.51M+78.9% | |
| Price / sales | 2×-0.5× | 3.3×-2.0× | 5.4×-2.8× | 8.2×+0.8× | |
| Price / book | 32.4×+25.3× | 7.4×-0.5× | 7.8×-1.2× | 9×+1.7× | |
| EV / EBITDA | 26.2×-5.7× | 86.5×— | —— | —— | |
| EV / sales | 2.4×-0.4× | 3.5×-2.0× | 5.5×-2.6× | 8.1×+1.3× | |
| Earnings yield | -14.8%-10.8pp | -3.3%-2.1pp | -1.2%+0.9pp | -2.1%+1.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Sanara MedTech Inc.'s profit margins?
- Sanara MedTech Inc. (SMTI) runs a 92.9% gross margin and a 6.1% operating margin, with a -31.2% net margin.
- Where do Sanara MedTech Inc.'s ratios come from?
- Every ratio is computed from Sanara MedTech Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
